Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
The Journal of ECT|August 27, 2016
Computer-Assisted Cognitive Behavior Therapy to Prevent Relapse Following Electroconvulsive TherapySamuel T Wilkinson, Robert B Ostroff, Gerard Sanacora
The Journal of Clinical Psychiatry|August 1, 2018
Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric HospitalSamuel T Wilkinson, Rachel B Katz, Mesut Toprak, et al.
Depression and Anxiety|April 16, 2016
KETAMINE: A POTENTIAL RAPID-ACTING ANTISUICIDAL AGENT?Samuel T Wilkinson, Gerard Sanacora
Drug Discovery Today|November 18, 2018
A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systemsSamuel T Wilkinson, Gerard Sanacora
Psychotherapy and Psychosomatics|May 11, 2017
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant DepressionSamuel T Wilkinson, DaShaun Wright, Madonna K Fasula, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|October 10, 2017
Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysisSamuel T Wilkinson, Gerard Sanacora, Michael H Bloch
Drug Discovery Today|November 4, 2023
Psychedelic renaissance: Revitalized potential therapies for psychiatric disordersTaeho Greg Rhee, Pasha A Davoudian, Gerard Sanacora, et al.
Contemporary Clinical Trials|March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocolSamuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
Focus (American Psychiatric Publishing)|April 16, 2025
Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for CliniciansSophie I Elliott, Rachel B Katz, Robert B Ostroff, et al.
Journal of Affective Disorders|October 19, 2017
Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State ScaleGerrit I van Schalkwyk, Samuel T Wilkinson, Larry Davidson, et al.
Pageof 22